Victory Capital Management Inc. Sells 165,508 Shares of Colgate-Palmolive (NYSE:CL)

Victory Capital Management Inc. cut its stake in shares of Colgate-Palmolive (NYSE:CL - Free Report) by 6.7% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 2,309,558 shares of the company's stock after selling 165,508 shares during the quarter. Victory Capital Management Inc. owned approximately 0.28% of Colgate-Palmolive worth $209,962,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the stock. D Orazio & Associates Inc. lifted its holdings in Colgate-Palmolive by 3.9% during the 3rd quarter. D Orazio & Associates Inc. now owns 2,862 shares of the company's stock worth $297,000 after buying an additional 108 shares during the period. Commonwealth Financial Services LLC lifted its holdings in Colgate-Palmolive by 4.5% during the 4th quarter. Commonwealth Financial Services LLC now owns 2,716 shares of the company's stock worth $247,000 after buying an additional 118 shares during the period. Lantz Financial LLC raised its position in shares of Colgate-Palmolive by 0.6% in the 4th quarter. Lantz Financial LLC now owns 20,140 shares of the company's stock worth $1,831,000 after acquiring an additional 122 shares in the last quarter. Horizon Kinetics Asset Management LLC raised its position in shares of Colgate-Palmolive by 4.2% in the 3rd quarter. Horizon Kinetics Asset Management LLC now owns 3,102 shares of the company's stock worth $322,000 after acquiring an additional 124 shares in the last quarter. Finally, Pine Haven Investment Counsel Inc raised its position in shares of Colgate-Palmolive by 1.0% in the 4th quarter. Pine Haven Investment Counsel Inc now owns 13,006 shares of the company's stock worth $1,182,000 after acquiring an additional 130 shares in the last quarter. 80.41% of the stock is owned by institutional investors and hedge funds.

Colgate-Palmolive Stock Up 0.9 %

Shares of Colgate-Palmolive stock traded up $0.81 on Wednesday, hitting $91.87. The company had a trading volume of 3,446,465 shares, compared to its average volume of 4,103,554. The company has a debt-to-equity ratio of 13.40, a quick ratio of 0.58 and a current ratio of 0.92. The stock has a market capitalization of $74.56 billion, a price-to-earnings ratio of 26.10, a P/E/G ratio of 4.20 and a beta of 0.44. The stock has a 50 day moving average of $88.72 and a 200-day moving average of $95.27. Colgate-Palmolive has a 1 year low of $85.32 and a 1 year high of $109.30.

Colgate-Palmolive (NYSE:CL - Get Free Report) last issued its quarterly earnings results on Friday, January 31st. The company reported $0.91 EPS for the quarter, beating analysts' consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same quarter in the prior year, the business earned $0.87 earnings per share. As a group, sell-side analysts forecast that Colgate-Palmolive will post 3.75 earnings per share for the current year.

Colgate-Palmolive Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, February 14th. Investors of record on Tuesday, January 21st were given a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.18%. The ex-dividend date was Tuesday, January 21st. Colgate-Palmolive's payout ratio is 56.82%.

Analyst Ratings Changes

Several research analysts have recently weighed in on the company. TD Cowen lowered their price objective on Colgate-Palmolive from $110.00 to $100.00 and set a "buy" rating for the company in a research report on Wednesday, January 8th. Barclays lowered their price objective on Colgate-Palmolive from $96.00 to $83.00 and set an "equal weight" rating for the company in a research report on Friday, January 17th. StockNews.com raised Colgate-Palmolive from a "hold" rating to a "buy" rating in a research report on Monday. Wells Fargo & Company lowered their price objective on Colgate-Palmolive from $92.00 to $83.00 and set an "underweight" rating for the company in a research report on Tuesday, January 7th. Finally, Royal Bank of Canada reissued a "sector perform" rating and issued a $101.00 price objective on shares of Colgate-Palmolive in a research report on Wednesday, January 29th. One analyst has rated the stock with a sell rating, nine have given a hold rating and twelve have issued a buy rating to the company's stock. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average price target of $101.61.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.